Board appoints Dr. Kelly Lee as representative to state Research Advisory Panel
Loading...
Summary
The board announced the appointment of Dr. Kelly Lee to the Research Advisory Panel of California under Health and Safety Code §11480 for a three-year term and requested annual presentations to the board on panel work.
The California State Board of Pharmacy announced the appointment of Dr. Kelly Lee to serve as the board’s representative on the Research Advisory Panel of California, a body established by Health and Safety Code section 11480 to review and authorize research into cannabis and hallucinogenic drugs.
The board’s executive officer said Dr. Lee’s appointment is for a three-year term and that she requested an annual presentation from the panel to keep the board informed on the panel’s work. No formal action was required of the board for this appointment.
Board materials included the statutory provision establishing the Research Advisory Panel and noted the appointment historically ran until retirement; the executive officer explained the three-year term is the current approach to the board’s representation on the panel.
